Literature DB >> 32144190

Association between age and readmission after percutaneous coronary intervention for acute myocardial infarction.

Yingyi Qin1, Xin Wei2, Hedong Han1, Yumeng Wen3, Kevin Gu4, Yiming Ruan1, Claire Huang Lucas5, Usman Baber6, Matthew I Tomey7, Jia He8,9.   

Abstract

OBJECTIVE: This study aimed to investigate the association between age and the risk of 30-day unplanned readmission among adult patients with acute myocardial infarction (AMI) undergoing percutaneous coronary intervention (PCI).
METHODS: This retrospective analysis included patients from the Nationwide Readmissions Database with AMI who underwent PCI during 2013-2014. We used multivariable logistic regression model to calculate adjusted odds ratios (AORs) for risk of readmission. To examine potential non-linear association, we performed logistic regression with restricted cubic splines (RCS).
RESULTS: Of the 492 550 patients with AMI aged above 18 years undergoing PCI during the index hospitalisation, 48 630 (9.87%) were readmitted within 30 days. Although the crude readmission rate of younger patients (aged 18-54 years) was the lowest (7.27%), younger patients had higher risk of readmission compared with patients aged 55-64 years for all-causes (AOR 1.06 (1.01 to 1.11), p=0.0129) and specific causes, such as AMI and chest pain (both cardiac and non-specific) after adjusted for covariates. Patients aged 65-74 years were at lower risk of all-cause readmission. Older patients (age ≥75 years) had higher risk of readmission for heart failure (AOR 1.50 (1.29 to 1.74)) and infection (AOR 1.44 (1.16 to 1.79)), but lower risk for chest pain. RCS analyses showed a U-shaped relationship between age and readmission risk.
CONCLUSIONS: Our results suggest higher risk of readmission in younger patients for all-cause unplanned readmission after adjusted for covariates. The trends of readmission risk along with age were different for specific causes. Age-targeted initiatives are warranted to reduce preventable readmissions in patients with AMI undergoing PCI. © Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  acute myocardial infarction; percutaneous coronary intervention; readmission; restricted cubic splines

Mesh:

Year:  2020        PMID: 32144190     DOI: 10.1136/heartjnl-2019-316103

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  5 in total

1.  Establishment and Application of a Novel Difficulty Scoring System for da Vinci Robotic Pancreatoduodenectomy.

Authors:  Hongfa Sun; Chuandong Sun; Bingyuan Zhang; Kai Ma; Zehua Wu; Brendan C Visser; Bing Han
Journal:  Front Surg       Date:  2022-06-01

2.  Temporal Trends and Patient Characteristics Associated with 30-Day Hospital Readmission Rates after a First Acute Myocardial Infarction.

Authors:  Mayra Tisminetzky; Jordy Mehawej; Ruben Miozzo; Jerry H Gurwitz; Joel M Gore; Darleen Lessard; Hawa O Abu; Benita A Bamgbade; Jorge Yarzebski; Edgard Granillo; Robert J Goldberg
Journal:  Am J Med       Date:  2021-04-20       Impact factor: 5.928

3.  Application Effect of Intelligent Monitoring of Emergency Nursing Process Reengineering in the Thrombolytic Therapy of Acute Myocardial Infarction.

Authors:  Xueqing Liu; Sufang Huang; Jing Cheng; Ying Zhang
Journal:  Contrast Media Mol Imaging       Date:  2021-11-22       Impact factor: 3.161

4.  Association Between Base Excess and Mortality Among Patients in ICU With Acute Kidney Injury.

Authors:  Yi Cheng; You Zhang; Boxiang Tu; Yingyi Qin; Xin Cheng; Ran Qi; Wei Guo; Dongdong Li; Shengyong Wu; Ronghui Zhu; Yanfang Zhao; Yuanjun Tang; Cheng Wu
Journal:  Front Med (Lausanne)       Date:  2021-12-02

5.  ST-Elevation Acute Myocardial Infarction in a Young Man.

Authors:  Daisuke Usuda; Risa Tanaka; Makoto Suzuki; Hayabusa Takano; Yuta Hotchi; Shintaro Shimozawa; Shungo Tokunaga; Ippei Osugi; Risa Katou; Sakurako Ito; Kentaro Mishima; Akihiko Kondo; Keiko Mizuno; Hiroki Takami; Takayuki Komatsu; Jiro Oba; Tomohisa Nomura; Manabu Sugita
Journal:  J Med Cases       Date:  2022-06-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.